urostim

composed of lysed bacterial cells and their lysates of 4 bacterial species: 2 strains of E. coli (type I pili and an Rc mutant), K. pneumoniae, P. mirabilis, and Enterococcus faecalis

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Nenkov, P: 1 article (01/2000)

Related Diseases

1.	Infections 01/01/2000 - "Overview on the clinical studies with Urostim immunostimulator against urogenital infections." 01/01/1993 - "In two groups of 25 urological patients each, with and free of urinary infection, Urostim is administered fifteen days before and after the operation. " 01/01/1993 - "[Preoperative immunoprophylaxis in wound and urinary infections in urological patients with Urostim]."
2.	Wounds and Injuries (Trauma) 01/01/1993 - "[Preoperative immunoprophylaxis in wound and urinary infections in urological patients with Urostim]."